| Clinical features and therapeutic outcomes in men with advanced prostate cancer and DNA mismatch repair gene mutations ES Antonarakis, F Shaukat, PI Velho, H Kaur, E Shenderov, DM Pardoll, ... European urology 75 (3), 378-382, 2019 | 185 | 2019 |
| Comparing the analytical performance of three SARS-CoV-2 molecular diagnostic assays K Uhteg, J Jarrett, M Richards, C Howard, E Morehead, M Geahr, L Gluck, ... Journal of Clinical Virology 127, 104384, 2020 | 132 | 2020 |
| Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer HB Kaur, LB Guedes, J Lu, L Maldonado, L Reitz, JR Barber, ... Modern Pathology 31 (10), 1539-1552, 2018 | 93 | 2018 |
| Homologous recombination deficiency (HRD) score in germline BRCA2-versus ATM-altered prostate cancer TL Lotan, HB Kaur, DC Salles, S Murali, EM Schaeffer, JS Lanchbury, ... Modern Pathology 34 (6), 1185-1193, 2021 | 82 | 2021 |
| Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapy S Wilkinson, H Ye, F Karzai, SA Harmon, NT Terrigino, DJ VanderWeele, ... European Urology, 2021 | 71 | 2021 |
| TP53 missense mutation is associated with increased tumor-infiltrating T cells in primary prostate cancer HB Kaur, J Lu, LB Guedes, L Maldonado, L Reitz, JR Barber, ... Human pathology 87, 95-102, 2019 | 45 | 2019 |
| Genomic and clinicopathologic characterization of ATM-deficient prostate cancer H Kaur, DC Salles, S Murali, JL Hicks, M Nguyen, CC Pritchard, ... Clinical Cancer Research 26 (18), 4869-4881, 2020 | 40 | 2020 |
| Neuroendocrine differentiation in usual‐type prostatic adenocarcinoma: Molecular characterization and clinical significance H Kaur, I Samarska, J Lu, F Faisal, BL Maughan, S Murali, K Asrani, ... The Prostate 80 (12), 1012-1023, 2020 | 35 | 2020 |
| mTORC1 feedback to AKT modulates lysosomal biogenesis through MiT/TFE regulation K Asrani, S Murali, B Lam, CH Na, P Phatak, A Sood, H Kaur, Z Khan, ... The Journal of clinical investigation 129 (12), 5584-5599, 2019 | 34 | 2019 |
| mTORC1 loss impairs epidermal adhesion via TGF-β/Rho kinase activation K Asrani, A Sood, A Torres, D Georgess, P Phatak, H Kaur, A Dubin, ... The Journal of clinical investigation 127 (11), 4001-4017, 2017 | 34 | 2017 |
| CDKN1B Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate Cancer FA Faisal, S Murali, H Kaur, T Vidotto, LB Guedes, DC Salles, V Kothari, ... Clinical Cancer Research 26 (11), 2595-2602, 2020 | 28 | 2020 |
| Molecular Characterization and Clinical Outcomes of Primary Gleason Pattern 5 Prostate Cancer After Radical Prostatectomy P Isaacsson Velho, D Lim, H Wang, JC Park, HB Kaur, F Almutairi, ... JCO precision oncology 3, 1-13, 2019 | 28 | 2019 |
| SPINK1 expression is enriched in African American prostate cancer but is not associated with altered immune infiltration or oncologic outcomes post-prostatectomy FA Faisal, HB Kaur, JJ Tosoian, SA Tomlins, EM Schaeffer, TL Lotan Prostate cancer and prostatic diseases 22 (4), 552-559, 2019 | 21 | 2019 |
| DNA damage repair alterations are frequent in prostatic adenocarcinomas with focal pleomorphic giant‐cell features TL Lotan, HB Kaur, AM Alharbi, CC Pritchard, JI Epstein Histopathology 74 (6), 836-843, 2019 | 21 | 2019 |
| Association of B7‐H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer AA Mendes, J Lu, HB Kaur, SL Zheng, J Xu, J Hicks, AB Weiner, ... Cancer, 2022 | 18 | 2022 |
| Association between pathogenic germline mutations in BRCA2 and ATM and tumor-infiltrating lymphocytes in primary prostate cancer HB Kaur, T Vidotto, AA Mendes, DC Salles, WB Isaacs, ES Antonarakis, ... Cancer Immunology, Immunotherapy, 1-9, 2021 | 18 | 2021 |
| PIN‐like ductal carcinoma of the prostate has frequent activating RAS/RAF mutations HB Kaur, DC Salles, A Paulk, JI Epstein, JR Eshleman, TL Lotan Histopathology 78 (2), 327-333, 2021 | 14 | 2021 |
| Adenocarcinoma predominant pattern subtyping and nuclear grading in cytology: Is there a role in prognostication of advanced pulmonary adenocarcinomas? A Nambirajan, H Kaur, K Jangra, K Kaur, K Madan, SR Mathur, VK Iyer, ... Cytopathology 29 (2), 163-171, 2018 | 9 | 2018 |
| Primary ureteral lymphoma presenting as bilateral obstructive uropathy C Friedes, B Dietrick, H Kaur, AR Meyer, JS Winoker Urology Case Reports 33, 101296, 2020 | 3 | 2020 |
| ATM loss in primary prostate cancer: Analysis of> 1000 cases using a validated clinical-grade immunohistochemistry (IHC) assay. ES Antonarakis, HB Kaur, J Hicks, CC Pritchard, AM De Marzo, WB Isaacs, ... Journal of Clinical Oncology 37 (15_suppl), 5069-5069, 2019 | 3 | 2019 |
